STAGE IIB LUNG CANCER AJCC V8

This study is for people with inoperable, locally advanced non-small cell lung cancer. It compares the current standard treatment (chemotherapy plus standard radiation, followed by a year of immunotherapy or targeted pills) against a new approach that adds a short, intense burst …

This study is testing whether updating radiation treatment plans at set times during therapy can reduce damage to healthy heart and lung tissue in people with non-small cell lung cancer. Researchers want to see if this adaptive approach lowers side effects like lung inflammation …

This study is testing if a drug called canakinumab can prevent lung cancer in people who have suspicious, high-risk spots (nodules) in their lungs. About 50 participants will receive injections of the drug every 3 weeks for up to 8 cycles. The main goal is to see if the drug can …

This study is testing whether a special breathing exercise program before lung cancer surgery can help prevent serious lung problems like pneumonia after the operation. It involves 220 patients with early to mid-stage lung cancer. Half will do breathing muscle training with a dev…

This study is testing whether a yoga program for patients and their caregivers can improve physical function and quality of life during radiation treatment for lung or esophageal cancer. It will compare yoga sessions to educational sessions to see which helps patients walk farthe…

This study aims to see if providing patients with quality-of-life information helps them make better decisions about their early-stage lung cancer treatment. It compares two groups: one receives a fact sheet about life after surgery or radiation, and the other receives standard c…

This study aims to understand why some cancer patients develop severe diarrhea and colon inflammation (colitis) while taking powerful immunotherapy drugs called immune checkpoint inhibitors. Researchers will collect stool, blood, and tissue samples from 800 patients with melanoma…